Publicaciones en colaboración con investigadores/as de Public Health England (48)

2023

  1. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)

    Neuro-Oncology, Vol. 25, Núm. 3, pp. 580-592

2022

  1. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries

    The Lancet Child and Adolescent Health, Vol. 6, Núm. 6, pp. 409-431

2021

  1. Kaposi sarcoma incidence, survival and trends: Data from the information network on rare cancers in Europe (RARECAREnet)

    Cancer Epidemiology, Vol. 70

  2. The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)

    Neuro-Oncology, Vol. 23, Núm. 10, pp. 1765-1776

2019

  1. Epidemiology of rare cancers and inequalities in oncologic outcomes

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 3-11

  2. Human biomonitoring as a tool for exposure assessment in industrially contaminated sites (Icss). lessons learned within the ics and health european network

    Epidemiologia e Prevenzione, Vol. 43, Núm. 4, pp. 249-259

  3. Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 75-80

  4. Siti industriali contaminati e salute: risultati di un’indagine europea

    Epidemiologia e prevenzione, Vol. 43, Núm. 4, pp. 238-248

  5. Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 60-66

  6. Treatment challenges in and outside a network setting: Head and neck cancers

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 40-45

  7. Treatment challenges in and outside a network setting: Soft tissue sarcomas

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 31-39

  8. Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours

    European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 46-51

2018

  1. A review of exposure assessment methods for epidemiological studies of health effects related to industrially contaminated sites

    Epidemiologia e Prevenzione, Vol. 42, Núm. 5-6, pp. 21-36

  2. Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991–2010 (Automated Childhood Cancer Information System): a population-based study

    The Lancet Oncology, Vol. 19, Núm. 9, pp. 1159-1169

  3. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

    The Lancet, Vol. 391, Núm. 10125, pp. 1023-1075

  4. Trends in incidence of thick, thin and in situ melanoma in Europe

    European Journal of Cancer, Vol. 92, pp. 108-118

2017

  1. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

    The Lancet Oncology, Vol. 18, Núm. 8, pp. 1022-1039

  2. Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413](S0090825816314974)(10.1016/j.ygyno.2016.10.019)

    Gynecologic Oncology

  3. Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404](S009082581631575X)(10.1016/j.ygyno.2016.11.019)

    Gynecologic Oncology

  4. Geographical variability in survival of European children with central nervous system tumours

    European Journal of Cancer, Vol. 82, pp. 137-148